ENSC - Balance Sheet - Ensysce Biosciences, Inc.

Current Liabilities	2.21 M
Accounts Payable	1.36 M
Short-Term Debt	302 K
Other Current Liabilities	548 K
Non-Current Liabilities	10.1 K
Long-Term Debt	0
Other Non-Current Liabilities	10.1 K

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017
ASSETS
Cash & Cash Equivalents	3.5	1.1	3.1	12.3	0.2	1.1	1.7	2.1
Short Term Investments	0	0	0	0	0	195.3	202.9	200.1
Receivables	0.1	97.6 K	0.3	0.4	0	0	0.2	0
Inventory	0	0	(0.3)	(0.4)	0	0	0	0
Other Current Assets	1.7	1.1	1.9	3.0	0.2	0.1	87.1 K	0.2
Total Current Assets	5.3	2.3	5.3	15.7	0.3	1.2	1.9	2.3
PP&E	0	0	27.2 K	24 721.0	151	351	0	0
Intangible Assets	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	195.3	202.9	200.1
Other Long Term Assets	0.3	0.4	0.6	(24 720.2)	3.78 K	351	0	0
Other Assets	0	0	0	0	0	0	0	0
Total Assets	5.6	2.7	5.9	16.4	0.4	196.5	204.8	202.4
LIABILITIES
Accounts Payable	1.4	1.9	2.9	0.3	1.7	0.5	0	0
Short Term Debt	0.3	0.9	4.3	12.8	4.3	0	0	0
Other Current Liabilities	1.1	0.5	2.2	3.4	0.9	2.1	0.4	0.2
Total Current Liabilities	2.2	3.3	9.5	16.5	7.0	2.8	0.4	0.2
Long Term Debt	0	0	0.1	4.4	0	0	0	0
Deferred Tax Income	0	0	0	0	0	(7.6)	1.76 K	0
Other Liabilities	10.1 K	26.4 K	0.3	3.7	0	7.6	0	0
Total Liabilities	2.2	3.4	9.9	24.6	7.0	10.3	7.4	7.2
EQUITY
Common Stock	136	315	642	2.46 K	1.58 K	181.2	604	673
Retained Earnings	(129 544 299.0)	(121.6)	(110.9)	(85.8)	(56.0)	2.5	2.1	31.2 K
Other Accumulative Comprehensive Income/Loss	0	0	0	0	0	0	604	673
Total Equity	3.4	(0.7)	(4.3)	(8.4)	(6.7)	186.2	197.4	195.3
Total Liabilities and Equity	5.6	2.7	5.9	16.4	0.4	196.5	204.8	202.4
SHARES OUTSTANDING
Common Shares Outstanding	1.7	2.3	0.2	84 K	65.7 K	6.1	6.0	6.0

Free